Our website is dedicated to improving the quality of life of kidney patients all over the world, and helping them overcome the pain, fear and loneliness caused by kidney disease. Unlike other sites, we offer a comprehensive range of information and services, including kidney disease prevention, common causes, related diagnostic tests, symptoms, routine and alternative treatments, and daily care.It helps patients better understand the kidney disease, manage health, control the disease, and survive well with the disease .
Through this site's content update, you can receive first-hand news and information on the world's newest medicines for kidneys, treatment, home care skills, symptoms of different stages of kidney disease and proper treatment.More importantly, the discovery and research on kidneys will be Shared with you for free as a valuable resource.
The whole information in this websiet is provided by the Dr Zheng Falei. Zheng Falei has been engaged in doctor for over 40 years. Once he served as the director of urology department in Peking Union Medical College Hospital. And now he takes the charge of the 11th Central Committee of jiusan Society, the director of the Central Medical and Health Committee, the 10th Standing Committee of Beijing Municipal Commission. His researches focus on chronic kidney metabolic disorders and nutritional therapy, mechanism and intervention of the renal interstitial, renal tubular lesions and drug toxicity. He has published over 260 pieces of papers. And he has gained rich clinical experiences and combined theory and practice as well as high technology in diagnosis of difficult and complicated kidney disease.
Papers published by Doctor Zheng Falei
1.Influence and Analysis of Low-Dosage Steroid Therapy in Severe Aristolochic Acid Nephropathy Patients
2.VEGF Suppresses Epithelial-Mesenchymal Transition by Inhibiting the Expression of Smad3 and miR192, a Smad3-Dependent MicroRNA
3.VEGF Ameliorates Tubulointerstitial Fibrosis in Unilateral Ureteral Obstruction Mice Via Inhibition of Epithelial-Mesenchymal Transition
4.The Effects of Mycophenolate Mofetil on Renal Interstitial Fibrosis and Epithelial-Myofibroblast Translation in Adenine-Induced Renal Failure Rats
5.Effects of Induction of Tubular Epithelial-Myofibroblast Transition by Monocyte Chemoattractant Protein-1 and Mechanism Thereof: An in Vitro Experiment
6.Effect of Bone Morphogenetic Protein-7 on Monocyte Chemoattractant Protein-1 Induced Epithelial-Myofibroblast Transition and TGF-beta1-Smad 3 Signaling Pathway of HKC Cells
7.Altered Expression of Vascular Endothelial Growth Factor and Its Receptors in Transdifferentiated Human Proximal Tubular Epithelial Cells Induced by Transforming Growth Factor Beta1
8.Effect of BMP-7 on the Transdifferentiation of Cultured Human Tubular Epithelial Cell Induced by TGF-beta1
9.Expression of Orexin A, Orexin Receptor-1, and Ob-R of Hypothalamus in Rats with Chronic Renal Failure
10.Phenotypic Modulation of Mesangial Cells in Diabetic Rats and Effect of Tujian Mixture
He is also the Professor and Doctoral tutor at CAMS(Chinese Academy of Medical Sciences) and Peking Union Medical College Hospital.
He holds the office of chairman in Beijing Medical Association Nephrology Society and the vice director in Chinese Medical Association Nephrology Society.
She is the Consultation Center director and Research Center deputy director of Kidney Hospital China.
At present,Shan Hongyin M.D is the leader of expert group and research group in Kidney Hospital China.